IRVINE, CA--(MARKET WIRE)--Jun 19, 2007 -- HealthSonix, Inc. (Other OTC:HSXI.PK - News) (Frankfurt:H7S.F - News) announced today that it will commence joint marketing programs with its proprietary AquaSonix Therapy and a biologic therapy medication used in adults to reduce the signs and symptoms of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
